Health Care: Drugs

Prothena Corp PLC (PRTA: NASDAQ)

$52.67 3.07 | 6.19%
06/30/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 52.67
52 Week High 55.97
52 Week Low 16.71
Avg. Daily Vol. (Mil) 0.47
Beta (3 year) 0.06
Share Related Items
Mkt Cap (Mil) 1,647.83
Shares Out (Mil) 31.29
Float (Mil) 16.70
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 29.50
Current Ratio 29.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 85.77
Price/Book 5.94
Price/Cash Flow -41.80
Per Share Data
Earnings -1.51
Sales 0.61
Book Value 8.87
Cash Flow -1.26
Business Summary
Prothena Corp PLCis a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
General Information
Alexandra House
The Sweepstakes, Ballsbridge
Dublin, 4
www.prothena.com
Industry : Drugs
Sector: Health Care
Employees: 46
CEO: Dr. Dale Schenk,PhD
Short Interest
Current Month (Mil) 3.23
Previous Month (Mil) 2.95
Short Interest Ratio (Days) 7.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -13.90
Return on Investments -14.50
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PRTA

Latest PRTA Headlines from TheStreet

More Financial News for PRTA

Press Releases for PRTA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter